Advertisement
UK markets open in 2 hours 46 minutes
  • NIKKEI 225

    37,944.94
    +316.46 (+0.84%)
     
  • HANG SENG

    17,625.64
    +341.10 (+1.97%)
     
  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,347.00
    +4.50 (+0.19%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,425.39
    +131.13 (+0.26%)
     
  • CMC Crypto 200

    1,389.46
    +6.88 (+0.50%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?

Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?

Over the past several months, investors have gotten a few reminders that experimental vaccines can pose risks to trial participants. In turn, unexpected side effects and delays in the clinical trial process can punish stock prices. AstraZeneca's (NYSE: AZN) coronavirus vaccine trial is still on hold in the U.S. after a clinical trial participant experienced rare, severe, and potentially permanent side effects.